Skip to content

Safety and efficacy of transcatheter arterial micro-embolization for postherpetic neuralgia resistant to conservative treatment

Safety and efficacy of transcatheter arterial micro-embolization for postherpetic neuralgia resistant to conservative treatment - TAME for PHN

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025018
Enrollment
33
Registered
2016-12-01
Start date
2016-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic neuralgia refractory to conservative treatment

Interventions

Sponsors

Edogawa Hospital
Lead Sponsor
Multidisciplinary Pain Center, Aichi Medical University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients who were diagnosed as postherpetic neuralgia 2.Patients who maintain major organ (bone marrow, heart, liver, lung, kidney) function. 3.Patients who have been treated by conservative treatment for more than 3 months and persistent moderate to severe pain (NRS>5) 4.Within 3 years from disease onset 5. age>20, age<80 6. Provided written informed consent to undergo the procedure.

Exclusion criteria

Exclusion criteria: 1.Location of disease seems to be not feasible to insert catheter by the results of imaging assessment using contrast enhanced computed tomography 2.patients with more than 4 year history of pain 3.Severe arteriosclerosis 4.mental illness 5.Iodine Allergy 6.Reheumatoid disease 7.Fibromyalgia 8.Patients with severe cardiac disease, cerebrovascular disease, neurological disease, uncontrollable diabetic mellitus and hypertension, severe infection, intestinal bleeding, interstitial pneumonia, ascites fluid, pleural effusion. 9, neoplasm 10,Pregnant female

Design outcomes

Primary

MeasureTime frame
The prevalence of Adverse events

Secondary

MeasureTime frame
Change of Brief Pain Inventory score Change of pain NRS score Change of pain surface area per total body surface area Change of QOL score Change of Pain Catastrophizing scale Change of frequency and amount of other treatment

Countries

Japan

Contacts

Public ContactYuji Okuno

Edogawa Hospital Musculoskeletal Intervention Center

okuno@edogawa.or.jp03-3673-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026